Auro Laboratories Ltd

Auro Laboratories Ltd

₹ 250 -1.36%
24 Apr - close price
About

Incorporated in 1989, Auro Laboratories Ltd is in the business of Bulk Drugs[1]

Key Points

Business Overview:[1]
ALL manufactures generic Active Pharmaceutical Ingredients (APIs), with a focus on anti-diabetics like Metformin HCL, a first-line treatment for type 2 diabetes. It also offers toll and custom manufacturing of APIs and intermediaries on a contract basis.

  • Market Cap 156 Cr.
  • Current Price 250
  • High / Low 307 / 156
  • Stock P/E 44.8
  • Book Value 69.6
  • Dividend Yield 0.00 %
  • ROCE 20.4 %
  • ROE 20.5 %
  • Face Value 10.0

Pros

  • Company's working capital requirements have reduced from 116 days to 89.4 days

Cons

  • Stock is trading at 3.59 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of 2.76% over past five years.
  • Company has a low return on equity of 12.9% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
12.14 17.88 11.19 12.56 15.62 13.52 10.18 13.41 17.98 12.06 5.72 3.10 3.05
10.93 16.97 10.62 11.54 15.17 11.17 9.02 10.38 13.90 9.65 4.39 2.38 2.60
Operating Profit 1.21 0.91 0.57 1.02 0.45 2.35 1.16 3.03 4.08 2.41 1.33 0.72 0.45
OPM % 9.97% 5.09% 5.09% 8.12% 2.88% 17.38% 11.39% 22.60% 22.69% 19.98% 23.25% 23.23% 14.75%
0.02 0.28 0.05 -0.16 0.43 0.62 0.36 0.32 0.42 0.40 0.20 0.31 0.14
Interest 0.16 0.40 0.26 0.32 0.10 0.13 0.27 0.35 0.44 -0.32 0.25 0.28 0.25
Depreciation 0.26 0.24 0.25 0.25 0.27 0.30 0.27 0.27 0.27 0.28 0.27 0.27 0.27
Profit before tax 0.81 0.55 0.11 0.29 0.51 2.54 0.98 2.73 3.79 2.85 1.01 0.48 0.07
Tax % 24.69% 16.36% 27.27% 27.59% 27.45% 29.53% 27.55% 27.84% 27.70% 18.60% 24.75% 25.00% 28.57%
0.61 0.46 0.08 0.21 0.37 1.78 0.71 1.97 2.73 2.32 0.75 0.36 0.05
EPS in Rs 0.98 0.74 0.13 0.34 0.59 2.86 1.14 3.16 4.38 3.72 1.20 0.58 0.08
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
44.28 33.74 32.65 27.91 35.47 40.79 46.82 43.79 54.25 50.87 52.89 53.64 23.93
41.01 30.95 29.71 25.11 31.03 34.43 39.83 37.51 43.01 46.24 48.50 42.96 19.02
Operating Profit 3.27 2.79 2.94 2.80 4.44 6.36 6.99 6.28 11.24 4.63 4.39 10.68 4.91
OPM % 7.38% 8.27% 9.00% 10.03% 12.52% 15.59% 14.93% 14.34% 20.72% 9.10% 8.30% 19.91% 20.52%
0.06 0.06 0.24 0.42 0.53 0.51 0.96 0.97 0.76 1.09 0.94 1.50 1.05
Interest 1.85 1.53 1.66 1.66 1.18 1.21 0.87 0.58 0.46 0.83 0.81 0.74 0.46
Depreciation 0.72 0.74 0.72 0.68 0.86 0.93 1.01 1.02 1.04 1.02 1.07 1.09 1.09
Profit before tax 0.76 0.58 0.80 0.88 2.93 4.73 6.07 5.65 10.50 3.87 3.45 10.35 4.41
Tax % 0.00% 0.00% 0.00% 0.00% 72.01% 25.16% 27.51% 27.96% 31.62% 26.61% 28.99% 24.64%
0.77 0.58 0.80 0.88 0.82 3.53 4.40 4.05 7.18 2.84 2.44 7.79 3.48
EPS in Rs 1.24 0.93 1.28 1.41 1.32 5.66 7.06 6.50 11.52 4.56 3.91 12.50 5.58
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: 5%
5 Years: 3%
3 Years: 0%
TTM: -57%
Compounded Profit Growth
10 Years: 30%
5 Years: 12%
3 Years: 3%
TTM: -52%
Stock Price CAGR
10 Years: 41%
5 Years: 44%
3 Years: 35%
1 Year: 24%
Return on Equity
10 Years: 18%
5 Years: 17%
3 Years: 13%
Last Year: 20%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23
Reserves 0.09 0.67 1.47 2.35 3.18 6.75 11.18 15.27 22.35 25.29 27.97 35.73 37.13
16.75 14.80 16.41 12.62 4.95 9.20 8.09 3.16 3.16 13.78 6.41 26.25 34.22
6.75 5.14 4.67 4.49 12.45 8.23 7.97 7.68 10.15 9.66 15.38 17.52 6.45
Total Liabilities 29.82 26.84 28.78 25.69 26.81 30.41 33.47 32.34 41.89 54.96 55.99 85.73 84.03
10.68 10.51 9.80 9.13 13.00 13.02 14.59 14.24 13.56 13.61 12.62 22.15 21.61
CWIP 0.00 0.06 0.82 3.33 0.23 1.07 0.12 0.12 0.13 3.68 7.67 32.68 39.86
Investments 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05
19.09 16.22 18.11 13.18 13.53 16.27 18.71 17.93 28.15 37.62 35.65 30.85 22.51
Total Assets 29.82 26.84 28.78 25.69 26.81 30.41 33.47 32.34 41.89 54.96 55.99 85.73 84.03

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1.46 4.48 -0.78 7.88 6.49 6.05 6.87 9.30 12.82 -6.59 3.28 18.81
-0.52 -0.56 -0.73 -2.44 -2.20 -3.04 -3.19 -2.21 -3.51 -5.34 -5.08 -38.67
-0.79 -2.99 0.53 -5.34 -3.81 -1.77 -1.83 -5.52 -0.46 9.79 -8.18 19.09
Net Cash Flow 0.15 0.93 -0.98 0.09 0.47 1.24 1.86 1.58 8.85 -2.14 -9.98 -0.77

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 66.52 46.95 94.80 66.04 79.13 74.90 66.26 48.18 49.12 97.65 85.57 91.11
Inventory Days 72.37 115.33 89.37 86.72 21.65 22.00 42.98 60.54 32.60 47.32 120.27 113.24
Days Payable 64.73 62.97 56.12 72.03 80.26 78.26 66.19 70.67 73.51 54.12 117.41 85.34
Cash Conversion Cycle 74.17 99.30 128.05 80.73 20.52 18.64 43.05 38.04 8.20 90.86 88.44 119.01
Working Capital Days 89.27 94.12 138.51 97.17 67.20 64.70 63.46 51.09 33.84 123.56 134.64 89.41
ROCE % 11.71% 9.43% 10.74% 11.21% 23.06% 32.51% 29.11% 24.84% 38.87% 12.20% 9.92% 20.38%

Shareholding Pattern

Numbers in percentages

8 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
52.09% 52.09% 52.09% 52.09% 52.09% 52.09% 52.09% 52.15% 52.15% 52.15% 52.15% 52.17%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
47.91% 47.91% 47.92% 47.90% 47.90% 47.92% 47.90% 47.85% 47.84% 47.84% 47.84% 47.82%
No. of Shareholders 11,36211,18311,13510,90610,50110,2729,9059,4419,3359,2669,2659,102

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents